Clinical trials
Active, not recruiting Phase 2 Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| M.D. Anderson Cancer Center | 2 |
| Alain Algazi | 1 |
| Boston Scientific Corporation | 1 |
| Emory University | 1 |
| GlaxoSmithKline | 1 |
| National Cancer Institute (NCI) | 1 |
| Replimune, Inc. | 1 |
| Susanne Arnold | 1 |
| Wenjun Cheng | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 13 |
| Carcinoma, Squamous Cell | 3 |
| Neoplasms | 3 |
| Adenocarcinoma | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Head and Neck Neoplasms | 2 |
| Neoplasms by Histologic Type | 2 |
| Neoplasms by Site | 2 |
| Neoplasms, Glandular and Epithelial | 2 |
| Brain Neoplasms | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.